Boesgaard Lars's most recent trade in PDS Biotechnology Corporation was a trade of 300,000 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 12, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PDS biotech Corp | Lars Boesgaard | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jan 2026 | 300,000 | 300,000 | - | - | Employee Stock Option (Right to Buy) | |
| PDS biotech Corp | Lars Boesgaard | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 150,000 | 150,000 | - | - | Employee Stock Option (Right to Buy) | |
| PDS biotech Corp | Boesgaard Lars | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Dec 2023 | 200,000 | 200,000 | - | - | Employee Stock Option (Right to Buy) |